Limited TCR repertoire and ENTPD1 dysregulation mark late-stage COVID-19-Reference-Cited by-同舟云学术

Limited TCR repertoire and ENTPD1 dysregulation mark late-stage COVID-19

Published:2021-10 Issue:10 Volume:24 Page:103205
ISSN:2589-0042
Container-title:iScience
language:en
Short-container-title:iScience

Author:

Wang Na^ORCID,Vuerich Marta,Kalbasi Ahmadreza,Graham Jonathon J.^ORCID,Csizmadia Eva,Manickas-Hill Zachary James,Woolley Ann,David Clement,Miller Eric M.^ORCID,Gorman Kara,Hecht Jonathan L.,Shaefi Shahzad,Robson Simon C.^ORCID,Longhi Maria Serena

Funder

US Department of Defense

National Institutes of Health

Publisher

Elsevier BV

Subject

Multidisciplinary

Reference37 articles.

1. A single-nucleotide polymorphism in the human ENTPD1 gene encoding CD39 is associated with worsened graft-versus-host disease in a humanized mouse model;Adhikary;Immunol. Cell Biol.,2020

2. CCR4-dependent reduction in the number and suppressor function of CD4(+)Foxp3(+) cells augments IFN-gamma-mediated pulmonary inflammation and aggravates tuberculosis pathogenesis;Bertolini;Cell Death Dis.,2018

3. Inflammatory phenotyping predicts clinical outcome in COVID-19;Burke;Respir. Res.,2020

4. Peripheral immunophenotypes in children with multisystem inflammatory syndrome associated with SARS-CoV-2 infection;Carter;Nat. Med.,2020

5. Stat3 and Gfi-1 transcription factors control Th17 cell immunosuppressive activity via the regulation of ectonucleotidase expression;Chalmin;Immunity,2012

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. High frequencies of alpha common cold coronavirus/SARS-CoV-2 cross-reactive functional CD4+ and CD8+ memory T cells are associated with protection from symptomatic and fatal SARS-CoV-2 infections in unvaccinated COVID-19 patients;Frontiers in Immunology;2024-03-28

2. Purinergic signaling in the battlefield of viral infections;Purinergic Signalling;2023-12-01

3. Differential expression patterns of purinergic ectoenzymes and the antioxidative role of IL-6 in hospitalized COVID-19 patient recovery;Frontiers in Immunology;2023-09-25

4. Purinergic signaling pathway in severe COVID-19;Current Opinion in Pharmacology;2023-06

5. Parallel Dysregulated Immune Response in Severe Forms of COVID-19 and Bacterial Sepsis via Single-Cell Transcriptome Sequencing;Biomedicines;2023-03-03